Sabine Schertl

Evaluation of the Mammary Tumor Inhibiting Properties

Sabine Schertl, Ronald Gust, Richard Müller et al. · Archiv der Pharmazie · 1992 · 13 citations

Medicine, Medicinal Chemistry, Oncology +11

1-(2,6-Dichloro-4-hydroxyphenyl)-2-phenylethanes — New Biological Response Modifiers for the Therapy of Breast Cancer. Synthesis and Evaluation of Estrogenic/Antiestrogenic Properties

Sabine Schertl, Rolf W. Hartmann, Christine Batzl‐Hartmann et al. · Archiv der Pharmazie · 2001 · 12 citations

Pharmacy, Medicinal Chemistry, Oncology +11

Development of a Parenterally Administrable Hydrosol Preparation of the “Third Generation Platinum Complex” [(±)‐1,2‐Bis(4‐fluorophenyl)ethylenediamine]dichloroplatinum(II). Part 1. Preparation and Studies on the Stability and Antitumor Activity

Ronald Gust, Günther Bernhardt, Thilo Spruß et al. · Archiv der Pharmazie · 1995 · 11 citations

Medicine, Medicinal Chemistry, Pharmacology +14

[1, 2‐Bis(2, 6‐difluoro‐3‐hydroxyphenyl)ethylene‐diamine]platinum(II) Complexes, Compounds for the Endocrine Therapy of Breast Cancer ‐ Mode of Action II: Contribution of Drug Inactivation, Cellular Drug Uptake and Sterical Factors in the Drug‐Target Interaction to the Antitumor Activity

Sabine Schertl, Rolf W. Hartmann, Christine Batzl‐Hartmann et al. · Archiv der Pharmazie · 2004 · 11 citations

Medicine, Medicinal Chemistry, Pharmacology +17

[1, 2‐Bis(2, 6‐difluoro‐3‐hydroxyphenyl)ethylene‐diamine]platinum(II) Complexes, Compounds for the Endocrine Therapy of Breast Cancer ‐ Mode of Action I: Antitumor Activity Due to the Reduction of the Endogenous Estrogen Level

Sabine Schertl, Rolf W. Hartmann, Christine Batzl‐Hartmann et al. · Archiv der Pharmazie · 2004 · 10 citations

Medicine, Oncology, Pharmacology +14